The aim of this new statement is to provide comprehensive and timely evidence-based
recommendations on the prevention of ischemic stroke among survivors of ischemic stroke or …

This scientific statement is intended for use by physicians and allied health personnel caring
for patients with transient ischemic attacks. Formal evidence review included a structured …

analyses, which are subject to both type I and type II error, should be interpreted cautiously.
Initiation of study drug up to 5 years after the index event is significantly beyond the high-risk …

The aim of this updated guideline is to provide comprehensive and timely evidence-based
recommendations on the prevention of future stroke among survivors of ischemic stroke or …

Background— Cardiovascular disease (CVD) is the leading cause of death in the United
States and is responsible for 17% of national health expenditures. As the population ages, …

Background Dual antiplatelet therapy with clopidogrel plus low-dose aspirin has not been
studied in a broad population of patients at high risk for atherothrombotic events. Methods We …

The aim of this updated statement is to provide comprehensive and timely evidence-based
recommendations on the prevention of ischemic stroke among survivors of ischemic stroke or …

Background and Purpose—Intracerebral hemorrhage (ICH) constitutes 10% to 15% of all
strokes and remains without a treatment of proven benefit. Despite several existing outcome …

ContextManagement of patients with acute transient ischemic attack (TIA) varies widely, with
some institutions admitting all patients and others proceeding with outpatient evaluations. …

Background We aimed to validate two similar existing prognostic scores for early risk of stroke
after transient ischaemic attack (TIA) and to derive and validate a unified score optimised …